From the genome to the microbiome and several omics in between, data are being generated that can provide significant biological insights into the disease.

Researchers have developed a quantitative MRI measure that reflects the joint contributions of neurodegeneration, brain infarcts, and white matter hyperintensities (WMH) to the clinical and pathologic diagnosis of late onset Alzheimer’s disease (LOAD).

Researchers at Weill Cornell Medicine have shown that measuring brain activity in response to hearing a brief narrative can identify patients with severe brain injury who have preserved high-level cognition despite showing limited or no consciousness at the bedside.